DS
PTLA

David Shaw’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

David Shaw’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-813,567
Closed -$5.8M – 4360
2020
Q1 		$5.8M Buy
813,567
+654,834
+413% +$8.17M 0.01% 1361
2019
Q4 		$3.79M Buy
+158,733
New +$4.38M ﹤0.01% 1954
2019
Q2 		– Sell
-13,235
Closed -$459K – 3984
2019
Q1 		$459K Buy
+13,235
New +$382K ﹤0.01% 3038
2018
Q4 		– Sell
-127,609
Closed -$2.62M – 4116
2018
Q3 		$3.4M Sell
127,609
-291,129
-70% -$9.51M ﹤0.01% 1833
2018
Q2 		$15.8M Sell
418,738
-393,384
-48% -$15M 0.02% 844
2018
Q1 		$26.5M Sell
812,122
-220,455
-21% -$9.67M 0.04% 549
2017
Q4 		$50.3M Buy
1,032,577
+2,555
+0.2% +$129K 0.07% 349
2017
Q3 		$55.7M Sell
1,030,022
-144,908
-12% -$8.51M 0.09% 295
2017
Q2 		$66M Buy
1,174,930
+519,440
+79% +$20.8M 0.11% 224
2017
Q1 		$25.7M Buy
655,490
+582,397
+797% +$18.5M 0.05% 477
2016
Q4 		$1.64M Sell
73,093
-116,133
-61% -$2.27M ﹤0.01% 2147
2016
Q3 		$4.3M Buy
189,226
+156,700
+482% +$3.68M 0.01% 1394
2016
Q2 		$768K Buy
32,526
+13,487
+71% +$333K ﹤0.01% 2566
2016
Q1 		$388K Sell
19,039
-45,104
-70% -$1.43M ﹤0.01% 2909
2015
Q4 		$3.3M Buy
64,143
+14,708
+30% +$713K ﹤0.01% 1746
2015
Q3 		$2.11M Sell
49,435
-44,345
-47% -$2.14M ﹤0.01% 2057
2015
Q2 		$4.27M Buy
93,780
+57,730
+160% +$2.32M 0.01% 1589
2015
Q1 		$1.37M Buy
36,050
+6,941
+24% +$238K ﹤0.01% 2311
2014
Q4 		$825K Buy
29,109
+13,582
+87% +$378K ﹤0.01% 2972
2014
Q3 		$393K Sell
15,527
-2,472
-14% -$65.1K ﹤0.01% 3525
2014
Q2 		$525K Buy
+17,999
New +$436K ﹤0.01% 3487
2013
Q4 		– Sell
-221,000
Closed -$5.91M – 4792
2013
Q3 		$5.91M Hold
221,000
– – 0.01% 1451
2013
Q2 		$5.43M Buy
+221,000
New +$4.39M 0.01% 1294

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

David Shaw's PTLA Position: Q2 2020 in Review

David Shaw sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 813,567 shares — an estimated $5.8M sold.

David Shaw first reported a position in PTLA in Q2 2013 and held it in 23 quarters. The position peaked at $66M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • David Shaw reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • David Shaw sold 813,567 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $5.8M.
  • David Shaw first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
  • David Shaw's Portola Pharmaceuticals, Inc. position peaked at $66M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on D.E. Shaw & Co's 13F filing for Q2 2020, filed 14 Aug 2020.